You're reading a SIGNA Wire case file. Get alerts like this for free. Sign in · Learn more →
Ascend Laboratories, LLCFDAMed source confidence · 80%Jun 22, 2026, 10:01 AM UTC · 16d ago

Ascend Laboratories, LLC — FDA Class II (D-0547-2026)

Case File

Ascend Laboratories, LLC is recalling 17,304 bottles of a human prescription drug due to failed dissolution specifications. This recall is classified as a safety issue. The affected products have NDC numbers 67877-590, 67877-591, 67877-592, and 67877-593.

Sign in to follow Ascend Laboratories, LLC and get alerts like this
Key Points
  • Ascend Laboratories is recalling 17,304 bottles of a human prescription drug.
  • The recall is due to failed dissolution testing.
  • Affected products have NDC numbers 67877-590 to 67877-593.
  • Patients should check their medicine cabinets for these products.
  • This recall is classified as a Class II safety issue.
Why This Matters

Patients using these drugs should stop immediately and consult their healthcare provider. The recall affects 17,304 bottles distributed nationwide.

View original filing →
Sign in to follow Ascend Laboratories, LLC and get alerts like this

SIGNA Wire provides informational summaries of official government filings. Not investment advice.